Terms: = Liver cancer AND TPM3, ENSG00000143549, 7170
21 results:
1. Elaboration of NTRK-rearranged colorectal cancer: Integration of immunoreactivity pattern, cytogenetic identity, and rearrangement variant.
Wu S; Liu Y; Shi X; Zhou W; Zeng X
Dig Liver Dis; 2023 Dec; 55(12):1757-1764. PubMed ID: 37142453
[TBL] [Abstract] [Full Text] [Related]
2. Vincristine/irinotecan/temsirolimus upfront window treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 Study Committee.
Thompson PA; Malogolowkin MH; Furman WL; Piao J; Krailo MD; Chung N; Brock L; Towbin AJ; McCarville EB; Finegold MJ; Ranganathan S; Dunn SP; Langham MR; McGahren ED; Tiao GM; Weldon CB; O'Neill AF; Rodriguez-Galindo C; Meyers RL; Katzenstein HM
Pediatr Blood Cancer; 2023 Jul; 70(7):e30365. PubMed ID: 37073741
[TBL] [Abstract] [Full Text] [Related]
3. [Establishment of artificial neural network model for predicting lymph node metastasis in patients with stage Ⅱ-Ⅲ gastric cancer].
Xue Z; Lu J; Lin J; Huang CM; Li P; Xie JW; Wang JB; Lin JX; Chen QY; Zheng CH
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Apr; 25(4):327-335. PubMed ID: 35461201
[No Abstract] [Full Text] [Related]
4. The prognostic value of TPM1-4 in hepatocellular carcinoma.
Tian Z; Zhao J; Wang Y
Cancer Med; 2022 Jan; 11(2):433-446. PubMed ID: 34850589
[TBL] [Abstract] [Full Text] [Related]
5. ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition.
Kemps PG; Picarsic J; Durham BH; Hélias-Rodzewicz Z; Hiemcke-Jiwa L; van den Bos C; van de Wetering MD; van Noesel CJM; van Laar JAM; Verdijk RM; Flucke UE; Hogendoorn PCW; Woei-A-Jin FJSH; Sciot R; Beilken A; Feuerhake F; Ebinger M; Möhle R; Fend F; Bornemann A; Wiegering V; Ernestus K; Méry T; Gryniewicz-Kwiatkowska O; Dembowska-Baginska B; Evseev DA; Potapenko V; Baykov VV; Gaspari S; Rossi S; Gessi M; Tamburrini G; Héritier S; Donadieu J; Bonneau-Lagacherie J; Lamaison C; Farnault L; Fraitag S; Jullié ML; Haroche J; Collin M; Allotey J; Madni M; Turner K; Picton S; Barbaro PM; Poulin A; Tam IS; El Demellawy D; Empringham B; Whitlock JA; Raghunathan A; Swanson AA; Suchi M; Brandt JM; Yaseen NR; Weinstein JL; Eldem I; Sisk BA; Sridhar V; Atkinson M; Massoth LR; Hornick JL; Alexandrescu S; Yeo KK; Petrova-Drus K; Peeke SZ; Muñoz-Arcos LS; Leino DG; Grier DD; Lorsbach R; Roy S; Kumar AR; Garg S; Tiwari N; Schafernak KT; Henry MM; van Halteren AGS; Abla O; Diamond EL; Emile JF
Blood; 2022 Jan; 139(2):256-280. PubMed ID: 34727172
[TBL] [Abstract] [Full Text] [Related]
6. Gd-EOB-DTPA-enhanced MRI-a noninvasive and short-term assessment method for liver necroinflammation after direct-acting antiviral (DAA) therapy in patients with chronic hepatitis C.
Li A; Wu J; Cheng J; Feng C; Liu W; Li Y; Rao H; Huang R; Zhou G; Hong N; Wang Y
Abdom Radiol (NY); 2022 Jan; 47(1):174-183. PubMed ID: 34664096
[TBL] [Abstract] [Full Text] [Related]
7. Establishment of Prognostic Nomograms for Predicting the Survival of HR-Positive, HER2-Negative Metastatic Breast cancer Patients Treated with Everolimus.
Duan F; Song C; Ma Y; Jiang K; Xu F; Bi X; Huang J; Hong R; Huang Z; Lu Q; Yuan Z; Wang S; Xia W
Drug Des Devel Ther; 2021; 15():3463-3473. PubMed ID: 34408400
[TBL] [Abstract] [Full Text] [Related]
8. Individual and neighborhood socioeconomic status in the prediction of liver transplantation among patients with liver disease: A population-based cohort study in Taiwan.
Liu CC; Lu CL; Notobroto HB; Tsai CC; Wen PH; Li CY
Medicine (Baltimore); 2019 Mar; 98(11):e14849. PubMed ID: 30882681
[TBL] [Abstract] [Full Text] [Related]
9. Foretinib Overcomes Entrectinib Resistance Associated with the
Nishiyama A; Yamada T; Kita K; Wang R; Arai S; Fukuda K; Tanimoto A; Takeuchi S; Tange S; Tajima A; Furuya N; Kinoshita T; Yano S
Clin Cancer Res; 2018 May; 24(10):2357-2369. PubMed ID: 29463555
[No Abstract] [Full Text] [Related]
10. In vivo imaging xenograft models for the evaluation of anti-brain tumor efficacy of targeted drugs.
Kita K; Arai S; Nishiyama A; Taniguchi H; Fukuda K; Wang R; Yamada T; Takeuchi S; Tange S; Tajima A; Nakada M; Yasumoto K; Motoo Y; Murakami T; Yano S
Cancer Med; 2017 Dec; 6(12):2972-2983. PubMed ID: 29125233
[TBL] [Abstract] [Full Text] [Related]
11. A New Treatment-integrated Prognostic Nomogram of the Barcelona Clinic liver cancer System for Hepatocellular Carcinoma.
Hsu CY; Liu PH; Hsia CY; Lee YH; Nagaria TS; Lee RC; Ho SY; Hou MC; Huo TI
Sci Rep; 2017 Aug; 7(1):7914. PubMed ID: 28801646
[TBL] [Abstract] [Full Text] [Related]
12. Sensitivity to Entrectinib Associated With a Novel LMNA-NTRK1 Gene Fusion in Metastatic Colorectal cancer.
Sartore-Bianchi A; Ardini E; Bosotti R; Amatu A; Valtorta E; Somaschini A; Raddrizzani L; Palmeri L; Banfi P; Bonazzina E; Misale S; Marrapese G; Leone A; Alzani R; Luo D; Hornby Z; Lim J; Veronese S; Vanzulli A; Bardelli A; Martignoni M; Davite C; Galvani A; Isacchi A; Siena S
J Natl Cancer Inst; 2016 Jan; 108(1):. PubMed ID: 26563355
[TBL] [Abstract] [Full Text] [Related]
13. Proteomic analysis of hepatocellular carcinoma HepG2 cells treated with platycodin D.
Lu JJ; Lu DZ; Chen YF; Dong YT; Zhang JR; Li T; Tang ZH; Yang Z
Chin J Nat Med; 2015 Sep; 13(9):673-9. PubMed ID: 26412427
[TBL] [Abstract] [Full Text] [Related]
14. Outcomes of surgical resection and loco-regional therapy in patients with stage 3A hepatocellular carcinoma: a retrospective review from the national cancer database.
Seshadri RM; Baker EH; Templin M; Swan RZ; Martinie JB; Vrochides D; Iannitti DA
HPB (Oxford); 2015 Nov; 17(11):964-8. PubMed ID: 26271743
[TBL] [Abstract] [Full Text] [Related]
15. Validation of hepatitis B virus-related hepatocellular carcinoma prediction models in the era of antiviral therapy.
Jung KS; Kim SU; Song K; Park JY; Kim DY; Ahn SH; Kim BK; Han KH
Hepatology; 2015 Dec; 62(6):1757-66. PubMed ID: 26249025
[TBL] [Abstract] [Full Text] [Related]
16. The effect of hepatic steatosis on survival following resection of colorectal liver metastases in patients without preoperative chemotherapy.
Parkin E; O'Reilly DA; Adam R; Kaiser GM; Laurent C; Elias D; Capussotti L; Renehan AG;
HPB (Oxford); 2013 Jun; 15(6):463-72. PubMed ID: 23458109
[TBL] [Abstract] [Full Text] [Related]
17. Identification and characterization of tropomyosin 3 associated with granulin-epithelin precursor in human hepatocellular carcinoma.
Lam CY; Yip CW; Poon TC; Cheng CK; Ng EW; Wong NC; Cheung PF; Lai PB; Ng IO; Fan ST; Cheung ST
PLoS One; 2012; 7(7):e40324. PubMed ID: 22792281
[TBL] [Abstract] [Full Text] [Related]
18. Tropomyosin3 overexpression and a potential link to epithelial-mesenchymal transition in human hepatocellular carcinoma.
Choi HS; Yim SH; Xu HD; Jung SH; Shin SH; Hu HJ; Jung CK; Choi JY; Chung YJ
BMC Cancer; 2010 Apr; 10():122. PubMed ID: 20356415
[TBL] [Abstract] [Full Text] [Related]
19. Clinical implication of recurrent copy number alterations in hepatocellular carcinoma and putative oncogenes in recurrent gains on 1q.
Kim TM; Yim SH; Shin SH; Xu HD; Jung YC; Park CK; Choi JY; Park WS; Kwon MS; Fiegler H; Carter NP; Rhyu MG; Chung YJ
Int J Cancer; 2008 Dec; 123(12):2808-15. PubMed ID: 18803288
[TBL] [Abstract] [Full Text] [Related]
20. Rapid kinetic rate assay of the serum alpha-L-fucosidase in patients with hepatocellular carcinoma by using a novel substrate.
Wang JJ; Cao EH
Clin Chim Acta; 2004 Sep; 347(1-2):103-9. PubMed ID: 15313147
[TBL] [Abstract] [Full Text] [Related]
[Next]
